×
收藏-健康|会员访问记?/h3>
| |页标题Q? | |
×
注册健康|用?/h3>
| ??名： | ||
|---|---|---|
| ?p?人： | ?nbsp; 别： | |
| ?nbsp; 码： | ||
| 重复密码Q?/th> | ||
| ?sh)子邮箱Q?/th> | ||
| 邮箱验证码： | ||
| 固定?sh)话Q?/th> | ||
| ?nbsp; 真： | ||
| ?nbsp; 机： | ||
| 单位名称Q?/th> | ||
| 通信地址Q?/th> | ||
| 首选栏目： | ||
| 我已l认真阅dƈ同意《健L服务条款?/a> | ||
| 定注册 | ||
| |页标题Q? | |
| ??名： | ||
|---|---|---|
| ?p?人： | ?nbsp; 别： | |
| ?nbsp; 码： | ||
| 重复密码Q?/th> | ||
| ?sh)子邮箱Q?/th> | ||
| 邮箱验证码： | ||
| 固定?sh)话Q?/th> | ||
| ?nbsp; 真： | ||
| ?nbsp; 机： | ||
| 单位名称Q?/th> | ||
| 通信地址Q?/th> | ||
| 首选栏目： | ||
| 我已l认真阅dƈ同意《健L服务条款?/a> | ||
| 定注册 | ||
(zhn)现在位|：健康|?医药产业 >> 研究报告 >> English reports >> English reports >> 览医药行业研究报告
健康|讯Q?/FONT>
Market report of second line drugs for nonsmall-cell lung cancer (NSCLC)
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: June 2007
Format: Adobe PDF
Price: US$ 1,200
Contact: Mr. Bian chenghua Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101 Fax: 86-10-68052525
E-mail: bianch@healthoo.com wuhf@healthoo.com
Table of contents
1QOverview of Chinese anticancer market
2QAanalysis on second line drugs for nonsmall-cell lung cancer
Docetaxel
Gefitinib
Pemetrexed
Appendix: Reatail prices of the three drugs
Tables or figures
1 Sales values of second line drugs for nonsmall-cell lung cancer in sample hospitals from 2005 to 2006
2 Sales amount of second line drugs for nonsmall-cell lung cancer in sample hospitals from 2005 to 2006
3 Sales statistic of Docetaxel with different specifications from 2005 to 2006
4 Detail statistic of Docetaxel in sample hospitals in 2005
5 Detail statistic of Docetaxel in sample hospitals in 2006
6 Detail statistic of Gefitinib in sample hospitals from 2005 to 2006
7 Sales statistic of Pemetrexed in sample hospitals in 2006
8 Reatail prices of the three drugs
|
||||||||||||||||